Bedel Financial Consulting, Inc. Viatris Inc Transaction History

Bedel Financial Consulting, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$9.95 - $12.27 $26,506 - $32,687	-2,664 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$9.81 - $15.4 $49 - $77	5 Added 0.19%	2,664 $29,000
Q4 2021 Jan 11, 2022	SELL	$12.09 - $14.68 $290 - $352	-24 Reduced 0.89%	2,659 $36,000
Q3 2021 Oct 12, 2021	SELL	$13.25 - $15.13 $636 - $726	-48 Reduced 1.76%	2,683 $36,000
Q2 2021 Aug 03, 2021	SELL	$12.97 - $16.15 $350 - $436	-27 Reduced 0.98%	2,731 $39,000
Q1 2021 Apr 26, 2021	BUY	$13.59 - $18.54 $7,773 - $10,604	572 Added 26.17%	2,758 $39,000
Q4 2020 Feb 02, 2021	BUY	$14.3 - $18.74 $31,259 - $40,965	2,186 New	2,186 $41,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.